HSBC Upgrades Gilead Sciences (GILD) to Buy
Analyst upgrade to Buy with higher target indicating positive near-term upside.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Analyst upgrade to Buy with higher target indicating positive near-term upside.
What happened, with direct paths to the underlying reporting
HSBC raises Gilead Sciences (GILD) to Buy with a $155 price target; current price is $131.27.
Target: $155
Posted price: $131.27
Analyst firm: HSBC
Analyst: Rajesh Kumar
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.